基于生成式人工智能的低剂量数字减影血管造影减少术中辐射剂量:一项随机对照试验
GenDSA-V2组较标准临床方案组显著降低辐射剂量,操作时间非劣效,术中并发症发生率相似。
要点
- GenDSA-V2组空气比释动能151.3±125.1 mGy,标准临床方案组457.4±407.4 mGy,平均差-306.1 mGy(95%CI -342.3至-269.9,优效性P<0.001)。
- GenDSA-V2组剂量面积乘积4009.7±2767.9 μGy m2,标准临床方案组12531.6±9145.9 μGy m2,平均差-8521.9 μGy m2(95%CI -9333.1至-7710.7,优效性P<0.001)。
- 平均操作时间标准临床方案组33.1±10.8 min,GenDSA-V2组34.8±11.8 min,平均差1.7 min(95%CI 0.3至3.1,非劣效性P<0.001)。
核心结论
- GenDSA系统在DSA引导操作中将医生和患者受到的辐射暴露降低约三分之二,具有显著的临床和转化价值。
研究设计与样本
- 共纳入1,068例符合手术标准的患者(干预组533例,对照组535例),其中疑似脑动脉瘤435例、肺癌417例、晚期肝癌216例,用于验证GenDSA-V2。
- 主要结局为辐射剂量,次要结局包括效率、操作时间和术中并发症。
- 分组对患者、外科医生和研究者设盲,技术人员知晓分组但不参与数据收集或分析。
主要发现
- GenDSA-V2组空气比释动能(AK)为151.3±125.1 mGy,标准临床方案(SCP)组为457.4±407.4 mGy,平均差-306.1 mGy(95%CI -342.3至-269.9,优效性P<0.001)。
- GenDSA-V2组剂量面积乘积(DAP)为4009.7±2767.9 μGy m2,SCP组为12531.6±9145.9 μGy m2,平均差-8521.9 μGy m2(95%CI -9333.1至-7710.7,优效性P<0.001)。
- SCP组平均操作时间为33.1±10.8 min,GenDSA-V2组为34.8±11.8 min,平均差1.7 min(95%CI 0.3至3.1,非劣效性P<0.001)。
- 并发症发生率相似:SCP组8.1%,GenDSA-V2组7.5%,平均差-0.6%(95%CI -3.8%至2.6%,非劣效性P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Digital subtraction angiography (DSA) devices guide procedures across numerous diseases, performed on more than 100,000 patients daily worldwide. However, these procedures expose patients and healthcare providers to radiation, increasing the risk of health issues. Despite many low-dose DSA imaging methods proposed, none have been prospectively clinically validated. In this study, 46,829 patients (over 5 million DSA images) from 70 centers were used to iterate our previously developed generative artificial intelligence system (named GenDSA-V2). A total of 1,068 patients (533 in intervention arm and 535 in control arm), with suspected cerebral aneurysms (n = 435), lung cancer (n = 417) or advanced liver cancer (n = 216), meeting surgical criteria, were enrolled to validate the GenDSA-V2. The primary outcome was radiation dose, while secondary outcomes included efficiency, operation time and intraoperative complications. Group assignments were blinded to patients, surgeons and investigators, while technicians were aware but not involved in data collection or analysis. The GenDSA-V2 group showed substantially reduced radiation exposure, with an air kerma (AK) of 151.3 ± 125.1 mGy compared to 457.4 ± 407.4 mGy in the standard clinical protocols (SCP) group (mean difference = -306.1 mGy, 95% confidence interval (CI) = -342.3 to -269.9, P < 0.001 for superiority) and a dose-area product (DAP) of 4009.7 ± 2767.9 μGy m2 versus 12531.6 ± 9145.9 μGy m2 (mean difference = -8521.9 μGy m2, 95% CI = -9333.1 to -7710.7, P < 0.001 for superiority). Mean operation time was 33.1 ± 10.8 min in the SCP group and 34.8 ± 11.8 min in the GenDSA-V2 group (mean difference = 1.7 min, 95% CI = 0.3 to 3.1, P < 0.001 for noninferiority). Complication rates were similar (SCP = 8.1%, GenDSA-V2 = 7.5%, mean difference = -0.6%, 95% CI = -3.8% to 2.6%, P < 0.001 for noninferiority). The GenDSA system reduces radiation exposure to both physicians and patients by approximately two-thirds during DSA-guided procedures, demonstrating substantial clinical and translational value. Chinese Clinical Trial Registry: ChiCTR2400084789 .
引用
- Zhao H, Bai Y, Chen L, et al. Generative AI-based low-dose digital subtraction angiography for intra-operative radiation dose reduction: a randomized controlled trial. Nat Med. 2026. PMID: 41482562. doi:10.1038/s41591-025-04042-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。